To buy or not to buy Abbott Labs? In this video, Fool health care analyst Brenton Flynn gives three reasons why you should. First, health care spending is likely to grow both in the U.S. and in emerging markets. Second, Abbott's nutrition division offers not only baby formula that is increasingly popular in emerging markets, but also diet supplements for older adults, a growing market domestically. Lastly, Abbott should increase its earnings by streamlining its operations and improving business efficiency.
Motley Fool Returns
Stock Advisor S&P 500
5 Years 55% 38%
17+ years 346% 95%
Stock Advisor launched in February of 2002. Returns as of 11/20/2019.Join Stock Advisor